Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Anflu® in Pregnant Women
NCT07832201Phase 4Not yet recruiting
- Sponsor
- Sinovac Biotech Ltd.
- Start
- Oct 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
A Phase 4 trial of seasonal split influenza vaccine in influenza, sponsored by Sinovac Biotech Ltd.. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
seasonal split influenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on NCT07832201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07832201.